Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India

Patel, Atul, Agarwal, Ritesh, Rudramurthy, Shivaprakash M., Shevkani, Manoj, Xess, Immaculata, Sharma, Ratna, Savio, Jayanthi, Sethuraman, Nandini +12 more·2021·Emerging Infectious Diseases

Cited by (485)

Items 101–200 of 485

  1. Mucormycosis in pre ‐COVID ‐19 and COVID ‐19 era: A study of prevalence, risk factors and clinical features
    Parisa Arjmand, Milad Bahrami, Zahra Eslami Mohammadie, Mohammadhossein Taherynejad, Negar Yeganeh Khorasani, Hassan Mehrad‐Majd, Imaneh Roshanzamir, Mehdi Bakhshaee · 2022 · Laryngoscope Investigative Otolaryngology
  2. Histomorphological features of mucormycosis with rise and fall of COVID-19 pandemic
    Nidhya Ganesan, Shanthakumari Sivanandam · 2022 · Pathology - Research and Practice
  3. Invasive Fungal Infections Associated with COVID-19
    Kyaw M Hlaing, Lea Monday, Márcio Nucci, Simone Aranha Nouér, Sanjay G. Revankar · 2023 · Journal of Fungi
  4. COVID-19 associated Mucormycosis (CAM): Should Brazil be on alert?
    Luís Arthur Brasil Gadelha Farias, Lisandra Serra Damasceno, Silviane Praciano Bandeira, Francisca Kalline de Almeida Barreto, Terezinha do Menino Jesus Silva Leitão, Luciano Pamplona de Góes Cavalcanti · 2021 · Revista da Sociedade Brasileira de Medicina Tropical
  5. Online Registry of COVID-19–Associated Mucormycosis Cases, India, 2021
    Shitij Arora, Vagish S. Hemmige, Charuta Mandke, Mayank Chansoria, Sumit Kumar Rawat, Ameet N. Dravid, Yatin Sethi, Gaurav Medikeri, Sunit P Jariwala, Yoram A. Puius et al. · 2021 · Emerging infectious diseases
  6. Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic
    Ravindra M. Mehta, Sameer Bansal, Hariprasad Kalpakkam · 2022 · Lung India
  7. A systematic review of mucormycosis cases in COVID-19: Is it an unholy trilogy of COVID-19, diabetes mellitus, and corticosteroids?
    Raman Kumar, Arup Kumar Misra, Siddhartha Dutta, Ajay Kumar Gupta, Bharat Kumar, Jaykaran Charan · 2022 · Journal of Family Medicine and Primary Care
  8. The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review
    Nahid Akhtar, Atif Khurshid Wani, Surya Kant Tripathi, Ajit Prakash, Mohammad Amin-ul Mannan · 2022 · Current Research in Biotechnology
  9. A case control investigation of COVID-19 associated mucormycosis in India
    Tanu Anand, Aparna Mukherjee, Aanchal Satija, Poonam Sharma Velamuri, Kh. Jitenkumar Singh, Madhuchhanda Das, Kripa Josten, Pragya Dhruv Yadav, Rima Rakeshkumar Sahay, Archana Y. Keche et al. · 2022 · BMC Infectious Diseases
  10. Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum
    Nikoletta Rovina, Evangelia Koukaki, Vasiliki Romanou, Sevasti Ampelioti, Konstantinos Loverdos, Vasiliki Chantziara, Antonia Koutsoukou, George Dimοpoulos · 2022 · Journal of Clinical Medicine
  11. Novel Approaches in the Management of Mucormycosis
    Frédéric Lamoth · 2023 · Current Fungal Infection Reports
  12. Incidence and Mortality of COVID-19 Associated Invasive Fungal Infections Among Critically-Ill Intubated Patients: A Multicenter Retrospective Cohort Analysis
    Julio Cesar Zuniga-Moya, Benjamin Papadopoulos, Armaghan‐e‐Rehman Mansoor, Patrick B Mazi, Adriana M. Rauseo, Andrej Spec · 2022 · Open Forum Infectious Diseases
  13. Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients
    Francesca Raffaelli, Eloisa Sofia Tanzarella, Gennaro DE PASCALE, Mario Tumbarello · 2022 · Journal of Fungi
  14. Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India
    Hari Shankar Meshram, Vivek Kute, Sanshriti Chauhan, Ruchir Dave, Himanshu V. Patel, Subho Banerjee, Sudeep Desai, Deepak Kumar, Vijay V. Navadiya, Vineet V Mishra · 2021 · International Urology and Nephrology
  15. Coronavirus Disease (COVID-19)
    Madhusudan Hiraman Fulekar, Geetika Madan Patel, Ashita Rai · 2025 · Springer eBooks
  16. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients
    Shyam Bihari Bansal, Abhyudaysingh Rana, Mayur Babras, Dinesh Kumar Yadav, Pranaw Kumar Jha, Manish Kumar Jain, Sidharth Kumar Sethi · 2021 · Transplant Infectious Disease
  17. Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease—Georgia, United States, 2017–2019
    Jeremy A.W. Gold, Andrew Revis, Stepy Thomas, Lewis Perry, Rebekah A. Blakney, Taylor Chambers, Meghan L. Bentz, Elizabeth L. Berkow, Shawn R. Lockhart, Colleen Lysén et al. · 2022 · Open Forum Infectious Diseases
  18. Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review
    Maria Panagiota Almyroudi, Karolina Akinosoglou, Jordi Rello, Stijn I. Blot, George Dimοpoulos · 2022 · Diagnostics
  19. COVID‐19‐associated acute invasive fungal sinusitis: Clinical and imaging findings
    Ali Hassan Elmokadem, Dalia Bayoumi, Manar Mansour, Mahitab Mohamed Rashad Ghoneim, Eman A Saad, Doaa Khedr · 2022 · Journal of Neuroimaging
  20. Risk factors for palatal and orbital involvement in mucormycosis epidemic–Report of a center in India
    Vikram Kemmannu Bhat, Kiran Ravindranath Bongale, Shriya Pramod Basti, Raveendra P. Gadag, Nikhila Kizhakkilottu, Eaiby Sebastian, Megha Kattayya Gopalegowda, Pavithra Thammaiah · 2021 · American Journal of Otolaryngology
  21. Social media disorder in relation to device screen time and autosuggested social media content engagement
    G. S. Prakasha, Anthony Kenneth, Maria Lapina · 2023 · Kontakt
  22. Correlates of depression, anxiety, self-esteem, and suicidal ideas in COVID-associated mucormycosis patients and the effects of treatment
    Amod Ahuja, Madhura Samudra, Shashi Prabha Prasad, Suprakash Chaudhury, Shivangi Bora, Varsha Singh, Nilay Dhore · 2021 · Industrial Psychiatry Journal
  23. A Clustered Case Series of Mucorales Detection in Respiratory Samples from COVID-19 Patients in Intensive Care, France, August to September 2021
    Emilie Guémas, Sophie Cassaing, S. Malavaud, Judith Fillaux, Pamela Chauvin, Lucie Lelièvre, Stéphanie Ruiz, Béatrice Riu, Antoine Berry, Xavier Iriart · 2022 · Journal of Fungi
  24. Mortality-Related Risk Factors for Coronavirus Disease (COVID-19)-Associated Mucormycosis: a systematic review and meta-analysis
    Vahid Reza Ostovan, Reza Tabrizi, Hanieh Bazrafshan, Zahra Bahrami, Hajar Khazraei, Samaneh Khazraei, Afshin Borhani‐Haghighi, Mohsen Moghadami, Matthew H. Grant · 2022 · Current Fungal Infection Reports
  25. Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study
    Deepak Kumar Garg, Soundappan Kathirvel, Ritesh Agarwal, Soham Mukherjee, Mahendra Kumar, Sahajal Dhooria, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Raja Ramachandran, Shivakumar Patil et al. · 2023 · Mycoses
  26. Review on Mucormycosis: Pathogenesis, Epidemiology, Microbiology and Diagnosis
    Aditya Sharma, Aftab Alam, Shivang Dhoundiyal, Pramod Kumar Sharma · 2023 · Infectious Disorders - Drug Targets
  27. Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific
    Cecilia Godoy Carvalhaes, Paul R. Rhomberg, Michael D. Huband, Michael A. Pfaller, Mariana Castanheira · 2023 · Journal of Fungi
  28. Clinical and Mycologic Characteristics of Emerging Mucormycosis Agent Rhizopus homothallicus
    Shivaprakash Mandya Rudramurthy, Shreya Singh, Rimjhim Kanaujia, Hansraj Chaudhary, Valliappan Muthu, Naresh Kumar Panda, Abhishek Kumar Pandey, Sheetal Thakur, Harsimran Kaur, Anup Kumar Ghosh et al. · 2023 · Emerging infectious diseases
  29. COVID-19-associated Pulmonary Cryptococcosis: A Rare Case Presentation
    Gyanendra Agrawal, Suryasnata Das, Smita Sharma · 2022 · Indian Journal of Critical Care Medicine
  30. Deciphering the Neurosensory Olfactory Pathway and Associated Neo-Immunometabolic Vulnerabilities Implicated in COVID-Associated Mucormycosis (CAM) and COVID-19 in a Diabetes Backdrop—A Novel Perspective
    Maryada Sharma, Hari Pankaj Vanam, Naresh Kumar Panda, Sourabha Kumar Patro, Rhythm Arora, Sanjay Kumar Bhadada, Shivaprakash Mandya Rudramurthy, Mini Pritam Singh, Purushotham Reddy Koppula · 2022 · Diabetology
  31. Serum glucose-regulated protein 78 (GRP78) levels in COVID-19-associated mucormycosis: results of a case–control study
    Valliappan Muthu, Manpreet Dhaliwal, Arunima Sharma, Divya Nair, Mohan Kumar H, Shivaprakash Mandya Rudramurthy, Inderpaul Singh Sehgal, Hansraj Choudhary, Naresh Kumar Panda, Arunaloke Chakrabarti et al. · 2022 · Mycopathologia
  32. Case report: COVID-19-associated mucormycosis co-infection with Lomentospora prolificans: The first case and review on multiple fungal co-infections during COVID-19 pandemic
    Mahzad Erami, Hossein Mirhendi, Mansooreh Momen–Heravi, Alireza Sharif, Seyed Jamal Hashemi Hezaveh, Amir Hassan Matini, Amir Hossein Ahsaniarani, Shima Aboutalebian · 2023 · Frontiers in Medicine
  33. Impact of COVID-19-associated Mucormycosis in Kidney Transplant Recipients: A Multicenter Cohort Study.
    Hari Shankar Meshram, Vivek Balkrishna Kute, Dinesh Kumar Yadav, Suraj M. Godara, Sonal Dalal, Sandeep Guleria, Anil Kumar Bhalla, Vivek Pathak, Urmila Anandh, Shyam Bihari Bansal et al. · 2021 · Transplantation Direct
  34. Notes from the Field: Mucormycosis Cases During the COVID-19 Pandemic — Honduras, May–September 2021
    Homer Mejía-Santos, Sandra Montoya, Rafael Chacón-Fuentes, Emily Zielinski-Gutiérrez, Beatriz López, Mariangeli Freitas Ning, Nasim Farach, Fany García-Coto, David S. Rodríguez-Araujo, Karla Rosales-Pavón et al. · 2021 · MMWR Morbidity and Mortality Weekly Report
  35. Multidisciplinary approach in diagnosis and treatment of COVID-19-associated mucormycosis: a description of current reports
    Hyma P. Gogineni, Wonhee So, Kenneth Mata, John Norman Greene · 2022 · The Egyptian Journal of Internal Medicine
  36. Serine/Threonine Phosphatase Calcineurin Orchestrates the Intrinsic Resistance to Micafungin in the Human-Pathogenic Fungus Mucor circinelloides
    Alexis Garcia, Eun Young Huh, Soo Chan Lee · 2023 · Antimicrobial Agents and Chemotherapy
  37. Rhino-orbital Mucormycosis in a COVID-19 Patient: The First Case in Malaysia
    Chee Yik Chang, Yi Lung Gan, Fatin Izni Zamri, Anuradha P. Radhakrishnan · 2022 · Proceedings of Singapore Healthcare
  38. Anu taila, an herbal nasal drop, suppresses mucormycosis by regulating host TNF-α response and fungal ergosterol biosynthesis
    Acharya Balkrishna, Shubhangi Rastogi, Bhawana Kharayat, Meenu Tomer, Yash Varshney, Kanchan Singh, Priya Kumari, Rishabh Dev, Jyotish Srivastava, Swati Haldar et al. · 2022 · Journal of Applied Microbiology
  39. COVID-19-Associated Rhino-Orbital Mucormycosis: Histological and Electron Microscopy Characteristics
    Ionuț Isaia Jeican, Delia Ioana Horhat, Mihai Dumitru, Adrian Florea, Lucian Barbu–Tudoran, Bogdan‐Alexandru Gheban, Vlad Anton, Corneliu Toader, Maria Aluaș, Costel Vasile Siserman et al. · 2024 · Diagnostics
  40. Brazilian task force for the management of mucormycosis
    Patrick Leon de Godoy Macedo, Mariane Taborda, Vítor Falcão de Oliveira, Adriana Satie Gonçalves Kono Magri, Lígia Lins Frutuoso, Gideane Mendes de Oliveira, Sinaida Teixeira Martins, Daniel Wagner de Castro Lima Santos, Fabianne Altruda de Moraes Costa Carlesse, Francelise Bridi Cavassin et al. · 2025 · The Brazilian Journal of Infectious Diseases
  41. Rare and Unusual Follow-up Sequelae of Coronavirus Disease 2019: Splenic Mucormycosis in a Renal Transplant Recipient
    Hari Shankar Meshram, Deepak Kumar, Vivek Balkrishna Kute · 2021 · Transplantation Proceedings
  42. Could cattle dung burning have contributed to the epidemic of COVID ‐19‐associated mucormycosis in India? Results of an experimental aero‐mycological study
    Soundappan Kathirvel, Valliappan Muthu, Shivaprakash Mandya Rudramurthy, Harsimran Kaur, Arunaloke Chakrabarti, Ritesh Agarwal · 2022 · Mycoses
  43. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India
    Sangeetha Kandasamy, Srinivas Muthuraju, Arumugam Vasugi, Megala Chandrasekar, Roopmala Murugan, Poovizhi Inbasekaran, R Prabu · 2022 · Cureus
  44. Isavuconazole for COVID-19-Associated Invasive Mold Infections
    Nadir Ullah, Chiara Sepulcri, Małgorzata Mikulska · 2022 · Journal of Fungi
  45. Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19
    Neelam Sharma, Shahid Nazir Wani, Tapan Behl, Sukhbir Singh, Ishrat Zahoor, Aayush Sehgal, Saurabh Bhatia, Ahmed Al‐Harrasi, Lotfi Aleya, SIMONA GABRIELA BUNGAU · 2022 · Environmental Science and Pollution Research
  46. Rapid detection of Mucorales based on recombinase polymerase amplification and real-time PCR
    Rui Li Xu, Dingchen Li, Jingya Zhao, Hanying Zhong, Hong Chen, Yajing Jia, Fangyan Chen, Li Han · 2023 · Frontiers in Microbiology
  47. Immune and metabolic perturbations in COVID ‐19‐associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells
    Manpreet Dhaliwal, Valliappan Muthu, Arunima Sharma, Khem Raj, Shivaprakash Mandya Rudramurthy, Ritesh Agarwal, Harsimran Kaur, Amit Kumar Rawat, Surjit Singh, Arunaloke Chakrabarti · 2023 · Mycoses
  48. Risk Factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study
    Bahram Eshraghi, Behzad Khademi, Majid Mirmohammadkhani, Gholamreza Khataminia, Hossein Ghahvehchian, Mohammad Yaser Kiarudi, Reza Nabie, Mohammad Mehdi Parandin, Paria Ghasemi Boroumand, Rasoul Mohammadi et al. · 2024 · BMC Infectious Diseases
  49. COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality?
    Ishika Mahajan, Aruni Ghose, Deepika Gupta, Manasi Manasvi, Saisha Bhandari, Aparimita Das, Elisabet Sanchez, Stergios Boussios · 2022 · Journal of Personalized Medicine
  50. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review
    Samendra Karkhur, Deepak Soni, Khushboo Chauhan, Deepayan Sarkar, Megha Gautam, Sunil Verma, Richa Nyodu, Nikita Singh Yadav, Bhavana B Sharma · 2022 · Indian Journal of Ophthalmology
  51. A novel indirect ELISA for serodiagnosis of mucormycosis using antigens from Rhizopus arrhizus
    Hansraj Choudhary, Harsimran Kaur, Shreya Singh, Rachna Singh, Valliappan Muthu, Roshan Kumar Verma, Shivaprakash Mandya Rudramurthy, Ritesh Agarwal, Sanjay Jain, Amanjit Bal et al. · 2024 · Mycoses
  52. Uncontrolled diabetes mellitus exacerbated by COVID-19–induced inflammation is the risk factor for COVID-19–associated rhino-orbito-cerebral mucormycosis: A matched pair case–control study
    Shubashree Karat, Aaron Charles Lobo, Deepthi Satish, Rincy Devaraj, Riya R Manjooran, Suneetha Nithyanandam · 2022 · Indian Journal of Ophthalmology
  53. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India
    Varshitha Hemanth Vasanthapuram, Roshmi Gupta, Namrata Gangaram Adulkar, Akshay Gopinathan Nair, Renuka Anil Bradoo, Raghuraj S. Hegde, Usha Singh, Sameeksha Haripriya Tadepalli, Bipasha Mukherjee, Saurabh Kamal et al. · 2022 · Orbit
  54. Prevalence of co‐existent COVID ‐19‐associated pulmonary aspergillosis ( CAPA ) and its impact on early mortality in patients with COVID ‐19‐associated pulmonary mucormycosis ( CAPM )
    Valliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, Deepak Thangaraju, Manoj Radhakishan Shevkani, Atul Kantilal Patel, Prakash Srinivas Shastri, Ashwini Tayade, Sudhir Bhandari, Vishwanath Gella et al. · 2024 · Mycoses
  55. Survival and quality-of-life in mucormycosis: a multicentric ambispective cohort study
    Rizwan Suliankatchi Abdulkader, Malu Mohan, Divya Saravana Kumar, Manickam Ponnaiah, Tarun Bhatnagar, Devika Shanmugasundaram, K Gayathri, Amanda G A Rozario, Aditya Moorthy, K. Devaraja et al. · 2025 · Clinical Microbiology and Infection
  56. Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment
    Wang-Da Liu, Jann‐Tay Wang, Chien‐Ching Hung, Shan‐Chwen Chang · 2021 · Journal of Microbiology Immunology and Infection
  57. Mucormycosis and diabetes in the times of COVID-19: A Mumbai-based observational study
    Anupa R. A. Hinduja, Rahul R. Tambe, Purshottam A. Giri, Suchithra Sunil, Harshad Limaye, G. Kalpana · 2022 · Journal of Family Medicine and Primary Care
  58. Prevalence of COVID-19 Associated Mucormycosis in a German Tertiary Care Hospital
    Ulrike Scharmann, Frank Herbstreit, Nina K. Steckel, Jutta Dedy, Jan Buer, Peter‐Michael Rath, Hedda Luise Verhasselt · 2022 · Journal of Fungi
  59. Mixed invasive fungal infections among COVID-19 patients
    Vanya Singh, Amber Prasad, Prasan Kumar Panda, Manjunath Totaganti, Amit Kumar Tyagi, Abhinav Thaduri, Shalinee Rao, Mukesh Chand Bairwa, Ashok Kumar Singh · 2022 · Current Medical Mycology
  60. Diabetes mellitus and other underlying conditions in patients with coronavirus disease 2019 associated rhino-orbito-cerebral mucormycosis: a systematic review and meta-analysis
    H Zobairy, M M Salem, M Ghajarzadeh, O Mirmosayyeb, M Mirsalehi · 2022 · The Journal of Laryngology & Otology
  61. Perturbations of immune landscape in COVID‐19 associated mucormycosis
    Nidhi Desai, Vandana Pradhan, Durga Chougule, Smrati Tiwari, Charuta Mandke, Reetika Malik Yadav, Amita Athvale, Juhi Kawle, Vinayak Pai, Swapnal Pawaskar et al. · 2022 · Mycoses
  62. Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies
    Kamal A. Hamed, Marc Frederick Engelhardt, Laura Lynn Kovanda, Jin Ju Huang, Jean Li Yan, Jalal A. Aram · 2023 · Scientific Reports
  63. 10th Trends in Medical Mycology Held on 8 to 11 October 2021, Aberdeen, Scotland, Organized by the European Confederation of Medical Mycology (ECMM)
    Oliver A. Cornely, Neil A. R. Gow, Martin Hoenigl, Adilia Warris · 2021 · Journal of Fungi
  64. COVID-19 associated with pulmonary mucormycosis; a case series
    Okba F. Ahmed, Saoud Y. Al-Neaimy, Fahmi H. Kakamad, Razhan K. Ali, Tomas M. Mikael, Ahmed G. Hamasaeed, Shvan Hussein Mohammed, Rawezh Qadir M. Salih, Abdulwahid M. Salh, Muhammed Gh Hamasaeed · 2022 · Annals of Medicine and Surgery
  65. Rhino-Orbital-Cerebral Mucormycosis in a Young Diabetic Patient with COVID-19 in Ethiopia: A Case Report
    Fikremariam Melkeneh Alemayehu, Hannibal Kassahun Abate, Tariku Assefa Soboka, Dawit Kebede Huluka, Alemayehu Bedane, Mahlet Abrie, Dawit Kibebew Dibaba, Yilkal Birhanu Asnake · 2022 · International Medical Case Reports Journal
  66. Sensitivity and Specificity of Polymerase Chain Reaction in Blood and Bronchoalveolar Lavage Samples for Mucormycosis: A Bayesian Diagnostic Test Accuracy Meta-Analysis
    Valliappan Muthu, Ritesh Agarwal, Sahajal Dhooria, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Shivaprakash Mandya Rudramurthy, Ashutosh N. Aggarwal, Arunaloke Chakrabarti · 2025 · Mycopathologia
  67. Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review
    Tarjani Vivek Dave, Akshay Gopinathan Nair, Joveeta Joseph, Suzanne K. Freitag · 2022 · Orbit
  68. Rise of mucormycosis during the COVID-19 pandemic and the challenges faced.
    Malavika Kottarathil, Thayanidhi Premamalini, P Sathyamurthy, Anupma Jyoti Kindo · 2023 · PubMed Central
  69. Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in patients With Hematologic Diseases
    Jieru Wang, Li Liu, Jia Li, Xiaomeng Feng, Huiming Yi, Erlie Jiang, Yizhou Zheng, Fengkui Zhang, Xiaofan Zhu, Yingchang Mi et al. · 2024 · Mycopathologia
  70. A Systematic Review and Meta‐Analysis of Low Dose Radiation Therapy for COVID ‐19 Pneumonia: Learnings of 4 Years Since Pandemic
    Usha Yadav, Balvinder Kaur Sapra · 2025 · Clinical and Translational Science
  71. Antifungal Policy and Practice Across Five Countries: A Qualitative Review
    David W. Denning, John R. Perfect, Neda Milevska Kostova, Artes Haderi, Hannah Armstrong, Maarten C. Hardenberg, Emily Chavez, Bruce M. Altevogt, Patrick Holmes, Jalal A. Aram · 2025 · Journal of Fungi
  72. Las infecciones fúngicas en la pandemia de COVID-19, el caso de la mucormicosis
    Norma Fernández · 2021 · Revista Argentina de Microbiología
  73. Cutaneous Mucormycosis in a Patient of Severe COVID-19 Pneumonia: A Rarer than Rare Case Report
    Amol Joshi, Rahul R. Tambe, Anupa R. A. Hinduja, Suchithra Sunil, A Varaiya · 2021 · Indian Journal of Critical Care Medicine
  74. Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study
    Yerasu Muralidhar Reddy, Sreekanth Yeduguri, Vishnu Swaroop Reddy N, Subhendu Parida, Shanti Naidu Kamatam, Lalitha Pidaparthi, Shyam Kumar Jaiswal, Bhavana Sadhvani, Vijaya K. Tourani, Sudhir Kumar et al. · 2022 · Journal de Mycologie Médicale
  75. Unmet needs and practical solutions in the management of invasive mould infections in Asia
    Yee‐Chun Chen, Methee Chayakulkeeree, Arunaloke Chakrabarti, Gin Gin Gan, Yok‐Lam Kwong, Wei‐Lun Liu, Ban Hock Tan, Subhash Kumar Todi · 2022 · Journal of Antimicrobial Chemotherapy
  76. Insights from Surgically treated Post Covid Acute Invasive Fungal Rhino-Orbital sinusitis in Chandrapur Study (SPAROS): A Population Based study of Coronavirus Associated Mucormycosis (CAM) characteristics in India
    Aakash Kasatwar, Ravindra Kumar Gayaprasad Shukla, Nivrutti Rathod, Jayshri Nandanwar, Divyangi Mishra, Akshay A. Dhobley · 2022 · IJID Regions
  77. Onset of Mucormycosis in Patients with COVID-19: A Systematic Review on Patients' Characteristics
    Shohreh Ghasemi, Mahmood Dashti, Amir Fahimipour, Ghazaleh Daryakenari, Fatemeh Mirzaei, Fatemeh Akbari, Zohaib Khurshid · 2022 · European Journal of Dentistry
  78. Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling
    Acharya Balkrishna, Sudeep Goswami, Hoshiyar Singh, Vivek Gohel, Rishabh Dev, Swati Haldar, Anurag Varshney · 2022 · Frontiers in Pharmacology
  79. Mucormycosis in a Patient with Severe COVID-19 Disease—The First Case Report in Romania and a Literature Review
    Beatrice Mahler, Oana Andreea Parliteanu, Octavian Alexe, Corina Popazu, Catalina Elena Ene, Bogdan Timar, Tudor Constantinescu · 2023 · Medicina
  80. Baseline findings of a multicentric ambispective cohort study (2021–2022) among hospitalised mucormycosis patients in India
    Rizwan Suliankatchi Abdulkader, Manickam Ponnaiah, Tarun Bhatnagar, Devika Shanmugasundaram, Amanda G A Rozario, K Gayathri, Malu Mohan, E. Michaelraj, Divya Saravanakumar, Aditya Moorthy et al. · 2024 · Mycology&#58 An International Journal on Fungal Biology
  81. Covid-associated pulmonary mucormycosis
    Arvind Kumar, Mohan Venkatesh Pulle, Belal Bin Asaf, Harsh Vardhan Puri · 2022 · Lung India
  82. A case of Covid-19-associated invasive pulmonary mucormycosis in a pediatric patient with a newly diagnosed diabetes
    Liliya Pekova, Maya Vladova Gulubova, Mehmed Hadzhi, Mitko Atanasov Mitev, S. Angelova · 2022 · Respiratory Medicine Case Reports
  83. Post-transcriptional control of antifungal resistance in human fungal pathogens
    Sharma, Cheshta, Kadosh, David · 2023 · Critical Reviews in Microbiology
  84. An Update on Fungal Disease Outbreaks of Public Health Concern
    Dallas J. Smith, Jeremy A.W. Gold, Samantha Williams, Ian Hennessee, Sophie Jones, Tom M Chiller · 2024 · Infectious Disease Clinics of North America
  85. Development and evaluation of a Pan-Mucorales Real-time PCR and a multiplex Real-time PCR for detection and identification of Rhizopus arrhizus, Rhizopus microsporus , and Mucor spp. in clinical specimens
    Helen M. Tang, Sharon C.-A. Chen, Kerri Basile, Catriona L Halliday · 2025 · Journal of Clinical Microbiology
  86. Emerging evidence for a multitude of mechanisms and factors that determine amphotericin B resistance in pathogenic fungi
    Anshu Chauhan, Neil A. R. Gow, Rajendra Prasad · 2026 · The Cell Surface
  87. COVID-19 Associated Mucormycosis (CAM)
    Manjunath Vijapur, Vasanth Kattimani, V. K. Varsha, HC Girish, Mamata Sharad Kamat, Bhargav Ram · 2022 · Journal of Oral and Maxillofacial Pathology
  88. Pharmacological management of invasive mold infections in solid organ transplant recipients
    Mario Fernández‐Ruiz · 2024 · Expert Opinion on Pharmacotherapy
  89. Real-World Effectiveness and Safety of Isavuconazole Versus Amphotericin B for Patients with Invasive Mucormycosis
    Jiayuan Qin, Hongxia Bi, Guangmin Tang, Xinyao Liu, Junyan Qu, Xiaoju Lv, Yanbin Liu · 2025 · Microorganisms
  90. Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus
    Rana Sadaqat Nawaz, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, Hansraj Choudhary, Ritika Harchand, Karthick Kumar, Inderpaul Singh Sehgal, Harsimran Kaur, Sahajal Dhooria, Kuruswamy Thurai Prasad et al. · 2025 · Mycoses
  91. Two Case of Rhino-Orbito-Cerebral Mucormicosis Developed After COVID-19 Infection
    Yusuf Zıya Demıroğlu, İlker Ödemiş, Ebru Oruç, Fulya Özer, Burak Ulaş, Tuba Canpolat, Çiğdem Yalçın, Özlem Öğüç Şanlı · 2021 · Mikrobiyoloji Bulteni
  92. Sensitivity of liquid‐based cytology in the diagnosis of mucormycosis in COVID ‐19 treated patients
    Rabish Kumar, Meeta Singh, Tanu Sagar, Bharanidharan, Nita Khurana, Vikas Kumar, Ravi Meher, Vikas Malhotra, Ruchi Goel, Sonal Saxena et al. · 2022 · Cytopathology
  93. Airway management, procedural data, and in-hospital mortality records of patients undergoing surgery for mucormycosis associated with coronavirus disease (COVID-19)
    Prashant Sirohiya, Saurabh Vig, Tanmay Mathur, Jitendra Kumar Meena, Smriti Panda, Gitartha Goswami, Raghav Gupta, Abhilash Konkimalla, Dheeraj Kondamudi, Nishkarsh Gupta et al. · 2022 · Journal de Mycologie Médicale
  94. Mucormycosis in Human Immunodeficiency Virus-Infected Individuals: A Systematic Review of Case Reports
    Valliappan Muthu, Ritesh Agarwal, Sahajal Dhooria, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Shivaprakash Mandya Rudramurthy, Ashutosh N. Aggarwal, Arunaloke Chakrabarti · 2023 · Mycopathologia
  95. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran
    Mahsa Abdorahimi, Farzad Pakdel, Mohammadreza Salehi, Laura Alcázar‐Fuoli, Seyed Jamal Hashemi, Roshanak Daie Ghazvini, Fardin Ahmadkhani, Kazem Ahmadikia, Alireza Abdollahi, Juan Carlos Soto-Debrán et al. · 2023 · Mycopathologia
  96. Satellite Epidemic of Covid-19 Associated Mucormycosis in India: A Multi-Site Observational Study
    Aanchal Satija, Tanu Anand, Aparna Mukherjee, Poonam Sharma Velamuri, Kh. Jitenkumar Singh, Madhuchhanda Das, Kripa Josten, Archana Y. Keche, Nitin Madhusudan Nagarkar, Prashant Gupta et al. · 2023 · Mycopathologia
  97. Demographic characteristics and risk factors for invasive fungal sinusitis in the context of COVID-19: A systematic review and meta-analysis
    Han Chen, Longgang Yu, Lin Wang, Jisheng Zhang, Xudong Yan, Yan Jiang · 2024 · International Journal of Infectious Diseases
  98. Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018–2022): An observational study
    Camille Estagnasie, Catherine Mohr, Laure Kamus, Patricia Zunic, Emmanuel Chirpaz, Marie‐Pierre Moiton, Marie Lagrange-Xélot · 2024 · Medical Mycology
  99. Isolation of fungi from the Trichosporonaceae family in urine samples from COVID-19 patients: Should we worry about it?
    Fernanda A. de Oliveira, Andréa Reis Bernardes‐Engemann, Fernando Almeida‐Silva, Beatriz da Silva Motta, Marcos de Abreu Almeida, Marcus de Melo Teixeira, Andrea D’Ávila Freitas, Kim Mattos Geraldo, Valdilea Gonçalves Veloso, Beatriz Gilda Jegerhorn Grinsztejn et al. · 2024 · Revista Iberoamericana de Micología
  100. Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis
    Junjun Wan, Teng Liu, Fang Li, Shaohua Xu · 2025 · PLoS ONE